January 2015

155. What Happens to the Cholesterol when the Dietary Fat is Altered?

The official dietary recommendations continue to advise a reduction in saturated fat (SFA) and an increase in the polyunsaturated fat (PUFA). The justification is that the SFA will reduce the Blood cholesterol (TC) and therefore lower the risk of developing heart disease. The same rationale is used to justify the advice to increase the intake […]

155. What Happens to the Cholesterol when the Dietary Fat is Altered? Read More »

153. Public Accounts Committee Report on Tamiflu and Publication of Drug Evaluation Results

A report from the House of Commons Public Accounts Committee concludes that information is routinely withheld from doctors and researchers about the methods and results of clinical trials on treatments currently prescribed in the United Kingdom (1). Invariably the bodies responsible for the approval of new drugs only have access to the results of studies

153. Public Accounts Committee Report on Tamiflu and Publication of Drug Evaluation Results Read More »

151. Praluent: New Cholesterol Drugs Get Riskier By The Day

This is a re-post of the article by Francois Lubbe of The Cholesterol Truth. I am most grateful to him for permission to post here. The original is available at http://www.thecholesteroltruth.com/praluent-cholesterol-drugs-side-effects-hypercholesterolemia/ Big Pharma seems intent in sticking to its backward way of thinking when it comes to cholesterol. So far their efforts, to create a

151. Praluent: New Cholesterol Drugs Get Riskier By The Day Read More »

Scroll to Top